Zimmer Holdings
Company
Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference...at 21st Annual Piper Jaffray Health Care Conference WARSAW, Ind., Nov. 24 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today it will be participating in the 21st Annual Piper Jaffray Health Care Conference... In this article: Zimmer Holdings, Piper Jaffray, Dental implant, NYSE, Warsaw, Indiana, Warsaw, and New York, New York |
-
Forbes.com News | 4 days ago
Gifts For Stockholders
...provider Praxair ( PX - news - people ), testing company Quest Diagnostics ( DGX - news - people ) and implantmaker Zimmer Holdings ( ZMH - news - people ) have mentioned the possibility of using newly raised cash from bond markets to buy back...
In this article: Earnings yield, Tobacco, Praxair, Quest Diagnostics, DGX, S&P 500, and Federal Reserve
-
AP Online | November 18, 2009
Sector Snap: UBS upbeat on medical tech stocks
...on nine of them. Analyst Bruce Nudell upgraded shares of medical device maker Boston Scientific Corp. and orthopedic implant maker Zimmer Holdings Inc. to "buy" from "neutral." He said stock prices throughout the sector should improve as...
In this article: Zimmer, Boston Scientific Corp., St. Jude Medical, Natick, Mass, Warsaw, Ind, and NEW YORK
-
Reuters | November 12, 2009
New Issue-Zimmer Holdings sells $1 bln in two parts
Nov 12 (Reuters) - Zimmer Holdings Inc <ZMH.N> on Thursday sold $1 billion of notes in two parts, said IFR, a Thomson Reuters service. Bank of America, Citigroup and JP Morgan were the joint bookrunning managers for the sale. BORROWER:...
In this article: S&P, Moody's, Thomson Reuters, JP Morgan, Bank of America, and Citigroup
-
Reuters | November 12, 2009
Zimmer Holdings sells $1 bln debt in 2 parts - IFR
Zimmer Holdings Inc <ZMH.N> on Thursday sold $1 billion of debt in a two-part sale, said IFR, a Thomson Reuters service. The offering included $500 million of 10-year notes priced to yield 118 basis points over comparable U.S. Treasuries...
In this article: Zimmer Holdings Inc, Thomson Reuters, JP Morgan, Bank of America Merrill Lynch, and Citigroup
-
San Francisco Chronicle | November 04, 2009
FDA panel rejects Zimmer spine implant
...Zimmer spine implant By MATTHEW PERRONE, AP Business Writer Federal health advisers on Wednesday rejected an implant from Zimmer Holdings saying it's unclear how effective or safe the device would be for treating a painful spinal...
In this article: Zimmer, Food and Drug Administration, Spinal fusion, Titanium, University of Florida College of Medicine, and Muscle weakness
-
Reuters | November 04, 2009
UPDATE 1-US panel rejects wider use of Zimmer spine device
...unclear, question long-term impact A U.S. panel of medical experts on Wednesday recommended against wider use of a Zimmer Holdings Inc <ZMH.N> spine stabilization device, questioning the company's data but adding that the device holds...
In this article: Zimmer, Food and Drug Administration, US, and New York Stock Exchange
-
The News Tribune | November 04, 2009
FDA panel has questions about Zimmer spine implant
Federal health officials say there are lingering questions about whether an implant from Zimmer Holdings Inc. is safe and effective for treating a painful spinal condition. The Food and Drug Administration's panel of outside experts says...
In this article: Zimmer, Food and Drug Administration, Titanium, and University of Pennsylvania
-
Indy Star | November 03, 2009
FDA questions role of payments in Zimmer study
WASHINGTON -- Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data. Zimmer...
In this article: Zimmer, Food and Drug Administration, Titanium, and Washington
-
South Bend Tribune | November 03, 2009
FDA questions Zimmer study :Concerned if payments swayed implant trial results.
...phone. Sign up here. Concerned if payments swayed implant trial results. WASHINGTON - Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether...
In this article: Zimmer, Food and Drug Administration, Titanium, and Washington
-
Reuters | November 02, 2009
UPDATE 3-FDA staff note financial ties in Zimmer spine study
By Lisa Richwine U.S. reviewers have raised the possibility of bias in the evaluation of a spine device made by Zimmer Holdings Inc <ZMH.N>, saying a majority of patients in a study were treated by researchers with a financial interest in...
In this article: Zimmer, Food and Drug Administration, Surgery, Spinal fusion, Muscle weakness, FDA, New York Stock Exchange, and U.S.
Trends
Loading...
More on Zimmer Holdings
Description from Wikipedia:
Zimmer Holdings Inc. (NYSE: ZMH) Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide. . ==External links==
* Official Website
- Name:
- Zimmer
- Type:
- Medical device
- Location:
- Warsaw, Indiana, USA
- Founded:
- Warsaw, Indiana, U.S. (1927)
- Stock Symbol:
- ZMH
- CEO:
- David Dvorak
- Revenue:
- US$ 3.9 billion (2007)
Explore everything named Zimmer Holdings...